Literature DB >> 26153378

The rationale for preventive treatments for early post-tympanostomy tube otorrhea in persistent otitis media with effusion.

Mohammad Faramarzi1, Sareh Roosta2, Mahmood Shishegar3, Rohollah Abbasi4, Saeid Atighechi5.   

Abstract

Some studies have shown that post-tympanostomy tube otorrhea (PTTO) is a common complication after tympanostomy tube insertion. There are wide range of controversies about the incidence of PTTO and different methods of preventive treatment. The aim of this study was to determine the incidence of early PTTO in persistent otitis media with effusion in our centers. We also investigated the effect of preventive treatments on the incidence of early PTTO in children with persistent otitis media with effusion. This multi-central study comprised 536 ears belonging to children with otitis media and effusion for at least 3 months, referred for complications arising from post-tympanostomy tube insertion. The patients were randomly divided into three treatment and control groups. In the first group of patients, the middle ear cavity was irrigated with isotonic saline after myringotomy. The second group received oral amoxicillin three times a day for 7 days postoperatively. The third group had similar treatment as the second group, in addition to topical ciprofloxacin drop, 4 drops three times a day for 3 days after operation. The control group did not undergo any treatment. Early post-tympanostomy tube otorrhea was detected in 6 ears (1.1 %), including 3 (2.2 %) from the control group and 3 (2.3 %) from the first group. There was no statistically significant difference in early PTTO between integrated treatment groups and control group (P = 0.111). As the total rate of early post-tympanostomy tube otorrhea was very low, there was no significant difference between the 3 treatment groups and control group. Our study did not support the routine use of preventive therapy. A period of at least 3 months watchful waiting before tympanostomy tube insertion may help reduce the incidence of PTTO.

Entities:  

Keywords:  Otitis media with effusion; Otorrhea; Tympanostomy tube

Mesh:

Substances:

Year:  2015        PMID: 26153378     DOI: 10.1007/s00405-015-3706-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  48 in total

1.  Comparison of characteristics of titanium and fluoroplastic ventilation tubes in adults with healthy middle ears.

Authors:  Ulrich Kisser; Robert Gürkov; Julia Louza; Florian Schrötzlmair; Christine Adderson-Kisser; Eike Krause
Journal:  Otol Neurotol       Date:  2012-08       Impact factor: 2.311

2.  Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years.

Authors:  J L Paradise; H M Feldman; T F Campbell; C A Dollaghan; D K Colborn; B S Bernard; H E Rockette; J E Janosky; D L Pitcairn; D L Sabo; M Kurs-Lasky; C G Smith
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

3.  Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes.

Authors:  E L Goldblatt; J Dohar; R J Nozza; R W Nielsen; T Goldberg; J D Sidman; M Seidlin
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1998-11-15       Impact factor: 1.675

4.  Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: prevalence, incidence, and duration.

Authors:  C Ah-Tye; J L Paradise; D K Colborn
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

5.  Low dose macrolide administration for long term is effective for otitis media with effusion in children.

Authors:  Kaitian Chen; Xuan Wu; Guangli Jiang; Jintao Du; Hongyan Jiang
Journal:  Auris Nasus Larynx       Date:  2012-06-04       Impact factor: 1.863

6.  Recurrent tube insertion for chronic otitis media with effusion in children over 6 years.

Authors:  Cinzia L Marchica; Jacob Pitaro; Sam J Daniel
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2012-12-13       Impact factor: 1.675

7.  Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.

Authors:  Peter S Roland; Jack B Anon; Richard D Moe; Peter J Conroy; G Michael Wall; Sheryl J Dupre; Kimberly A Krueger; Susan Potts; Gail Hogg; David W Stroman
Journal:  Laryngoscope       Date:  2003-12       Impact factor: 3.325

8.  Clinical characteristics of New York City children who received tympanostomy tubes in 2002.

Authors:  Salomeh Keyhani; Lawrence C Kleinman; Michael Rothschild; Joseph M Bernstein; Rebecca Anderson; Melissa Simon; Mark Chassin
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

9.  Biofilm formation on coated silicone tympanostomy tubes.

Authors:  Carolyn P Ojano-Dirain; Rodrigo C Silva; Patrick J Antonelli
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2012-11-30       Impact factor: 1.675

10.  Clinical practice guideline: Tympanostomy tubes in children.

Authors:  Richard M Rosenfeld; Seth R Schwartz; Melissa A Pynnonen; David E Tunkel; Heather M Hussey; Jeffrey S Fichera; Alison M Grimes; Jesse M Hackell; Melody F Harrison; Helen Haskell; David S Haynes; Tae W Kim; Denis C Lafreniere; Katie LeBlanc; Wendy L Mackey; James L Netterville; Mary E Pipan; Nikhila P Raol; Kenneth G Schellhase
Journal:  Otolaryngol Head Neck Surg       Date:  2013-07       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.